Heike E Daldrup-Link

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Accelerated stem cell labeling with ferucarbotran and protamine
    Daniel M Golovko
    Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA
    Eur Radiol 20:640-8. 2010
  2. pmc Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor staging
    Priyanka Jha
    Department of Radiology and Biomedical Imaging, University of California, San Francisco Medical Center, San Francisco, CA 94143 0628, USA
    Pediatr Radiol 40:1380-6. 2010
  3. pmc Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy
    Elizabeth J Sutton
    Department of Radiology, Mount Auburn Hospital, Harvard University, Cambridge, MA, USA
    Pediatr Radiol 39:1194-202. 2009
  4. ncbi request reprint Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX
    Heike E Daldrup-Link
    Department of Radiology, University of California San Francisco, UCSF Medical Center, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Acad Radiol 12:502-10. 2005
  5. ncbi request reprint Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Munich, Germany
    Radiology 234:197-205. 2005
  6. ncbi request reprint In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging
    Heike E Daldrup-Link
    Department of Radiology, UCSF Medical Center, 513 Parnassus Avenue, San Francisco, CA 94143 0628, USA
    Eur Radiol 15:4-13. 2005
  7. ncbi request reprint Imaging of tumor angiogenesis: current approaches and future prospects
    Heike E Daldrup-Link
    Department of Radiology, UCSF Medical Center, San Francisco, CA 94143, USA
    Curr Pharm Des 12:2661-72. 2006
  8. pmc MR imaging of therapy-induced changes of bone marrow
    Heike E Daldrup-Link
    Department of Radiology, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, 94143 0628, USA
    Eur Radiol 17:743-61. 2007
  9. ncbi request reprint Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy
    Heike E Daldrup-Link
    Department of Radiology, UCSF Medical Center, University of California in San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA
    Eur J Nucl Med Mol Imaging 31:1312-21. 2004
  10. doi request reprint Receptor imaging of pediatric tumors: clinical practice and new developments
    Heike E Daldrup-Link
    Department of Radiology, University of California at San Francisco, San Francisco, CA 94131, USA
    Pediatr Radiol 38:1154-61. 2008

Detail Information

Publications64

  1. pmc Accelerated stem cell labeling with ferucarbotran and protamine
    Daniel M Golovko
    Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA
    Eur Radiol 20:640-8. 2010
    ..To develop and characterize a clinically applicable, fast and efficient method for stem cell labeling with ferucarbotran and protamine for depiction with clinical MRI...
  2. pmc Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor staging
    Priyanka Jha
    Department of Radiology and Biomedical Imaging, University of California, San Francisco Medical Center, San Francisco, CA 94143 0628, USA
    Pediatr Radiol 40:1380-6. 2010
    ..Pancreatic metastases in childhood cancer have been rarely reported in the radiology literature although ample evidence exists in pathology reports for its occurrence in patients with alveolar rhabdomyosarcomas (RMS)...
  3. pmc Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy
    Elizabeth J Sutton
    Department of Radiology, Mount Auburn Hospital, Harvard University, Cambridge, MA, USA
    Pediatr Radiol 39:1194-202. 2009
    ....
  4. ncbi request reprint Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX
    Heike E Daldrup-Link
    Department of Radiology, University of California San Francisco, UCSF Medical Center, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Acad Radiol 12:502-10. 2005
    ..To compare and optimize ferumoxides labeling of human hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking with a clinical 1.5 T MR scanner...
  5. ncbi request reprint Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Munich, Germany
    Radiology 234:197-205. 2005
    ..To evaluate the use of clinical 1.5-T magnetic resonance (MR) imaging equipment to depict the in vivo distribution of iron oxide-labeled human hematopoietic progenitor cells in athymic mice...
  6. ncbi request reprint In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging
    Heike E Daldrup-Link
    Department of Radiology, UCSF Medical Center, 513 Parnassus Avenue, San Francisco, CA 94143 0628, USA
    Eur Radiol 15:4-13. 2005
    ....
  7. ncbi request reprint Imaging of tumor angiogenesis: current approaches and future prospects
    Heike E Daldrup-Link
    Department of Radiology, UCSF Medical Center, San Francisco, CA 94143, USA
    Curr Pharm Des 12:2661-72. 2006
    ..Superimposed data from MR imaging with spectroscopy, PET with CT, and PET with MR should be able to integrate advantages of different modalities yielding comprehensive information about tumor structure, function and microenvironment...
  8. pmc MR imaging of therapy-induced changes of bone marrow
    Heike E Daldrup-Link
    Department of Radiology, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, 94143 0628, USA
    Eur Radiol 17:743-61. 2007
    ..Future developments are directed to yield comprehensive information about bone marrow structure, function and microenvironment...
  9. ncbi request reprint Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy
    Heike E Daldrup-Link
    Department of Radiology, UCSF Medical Center, University of California in San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA
    Eur J Nucl Med Mol Imaging 31:1312-21. 2004
    ....
  10. doi request reprint Receptor imaging of pediatric tumors: clinical practice and new developments
    Heike E Daldrup-Link
    Department of Radiology, University of California at San Francisco, San Francisco, CA 94131, USA
    Pediatr Radiol 38:1154-61. 2008
    ....
  11. doi request reprint New perspectives on bone marrow contrast agents and molecular imaging
    Heike E Daldrup-Link
    Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California 94143 0628, USA
    Semin Musculoskelet Radiol 13:145-56. 2009
    ..Future developments of fusion imaging techniques and bifunctional contrast agents are directed to combine comprehensive information about bone marrow structure and function with targeted and image-guided therapies...
  12. ncbi request reprint Targeting of hematopoietic progenitor cells with MR contrast agents
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Ismaninger Str 22, 81675 Munich, Germany
    Radiology 228:760-7. 2003
    ..To label human hematopoietic progenitor cells with various magnetic resonance (MR) imaging contrast agents and to obtain 1.5-T MR images of them...
  13. doi request reprint Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133
    Reinhard Meier
    Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 0628, USA
    Radiology 255:527-35. 2010
    ..To assess the capability of the folate receptor (FR)-targeted ultrasmall superparamagnetic iron oxide (USPIO) P1133 to provide FR-specific enhancement of breast cancers on magnetic resonance (MR) images...
  14. ncbi request reprint MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA
    Gerhard H Simon
    Department of Radiology, UCSF Medical Center, University of California San Francisco, San Francisco, California 94143, USA
    J Magn Reson Imaging 23:720-7. 2006
    ..To compare the ability of the ultrasmall superparamagnetic iron oxide (USPIO) SHU555C vs. gadopentetate dimeglumine (Gd-DTPA) to detect antigen-induced monoarthritis with MRI...
  15. ncbi request reprint Cell labeling with the positive MR contrast agent Gadofluorine M
    Tobias D Henning
    Department of Radiology, University of California in San Francisco, 505 Parnassus Ave, San Francisco, CA, 94143, USA
    Eur Radiol 17:1226-34. 2007
    ..Potential in vivo cell-tracking applications include targeting of inflammatory processes with Gadofluorine-labeled leukocytes or monitoring of stem cell therapies for the treatment of arthritis...
  16. ncbi request reprint Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research
    Gerhard H Simon
    University of California at San Francisco Medical Center, Department of Radiology, S 372, Center for Pharmaceutical and Molecular Imaging, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Acad Radiol 12:1190-7. 2005
    ..The objective is to compare three different ultrasmall superparamagnetic iron oxides (USPIOs) for magnetic resonance (MR) imaging of normal bone marrow in rodents...
  17. doi request reprint Somatic differentiation and MR imaging of magnetically labeled human embryonic stem cells
    Hossein Nejadnik
    Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 94305, USA
    Cell Transplant 21:2555-67. 2012
    ....
  18. pmc Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI
    Aman Khurana
    Department of Radiology and Molecular Imaging Program at Stanford, Stanford University, Stanford, CA, USA
    Nanomedicine (Lond) 8:1969-83. 2013
    ..To develop a clinically applicable MRI technique for tracking stem cells in matrix-associated stem-cell implants, using the US FDA-approved iron supplement ferumoxytol...
  19. ncbi request reprint Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions
    Heike E Daldrup-Link
    Department of Radiology, Technical University of Munich, Insmaningerstr 22, 81675 Munich, Germany
    Acad Radiol 10:1237-46. 2003
    ..To compare the diagnostic performance of the blood pool agent feruglose and the standard extracellular contrast agent gadopentetate in their abilities to differentiate benign and malignant breast tumors...
  20. doi request reprint Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors
    Reinhard Meier
    Department of Radiology, University of California San Francisco, CA, USA
    Nucl Med Biol 35:579-88. 2008
    ..The objective of this study was to label the human natural killer (NK) cell line NK-92 with [(18)F]fluoro-deoxy-glucose (FDG) for subsequent in vivo tracking to HER2/neu-positive tumors...
  21. ncbi request reprint Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol
    Gerhard H Simon
    Department of Radiology, UCSF Medical Center, University of California, San Francisco, 94143, USA
    Invest Radiol 41:45-51. 2006
    ..We sought to compare the ability of 3 ultrasmall superparamagnetic iron oxides (USPIOs) to detect and characterize antigen-induced arthritis with MR imaging...
  22. pmc Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations
    Tobias D Henning
    Department of Radiology, University of Cologne, Cologne, Germany
    Mol Imaging 11:197-209. 2012
    ..The engraftment of iron oxide-labeled MASIs by simple incubation can be monitored over several weeks with MRI. Viable and apoptotic MASIs can be distinguished via imaging signs of cell proliferation at the transplantation site...
  23. pmc Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact
    Sophie E Boddington
    Department of Radiology, University of California, San Francisco, San Francisco, CA, USA
    Mol Imaging Biol 13:3-9. 2011
    ..This study aims to determine the effect of human mesenchymal stem cell (hMSC) labeling with the fluorescent dye DiD and the iron oxide nanoparticle ferucarbotran on chondrogenesis...
  24. pmc An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis
    Elizabeth J Sutton
    Department of Radiology, University of California, San Francisco, 185 Berry Street, Suite 350, San Francisco, CA 94107 0946, USA
    Opt Express 17:24403-13. 2009
    ..The experimental results indicate that DiD integrated into the cell membrane. DiD-labeled MSC localization in the arthritic ankle joints was observed with OI indicating that this method can be applied to monitor MSC in arthritic joints...
  25. ncbi request reprint Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
    Stephan Metz
    Department of Diagnostic Radiology, Technical University Munich, Munich, Germany
    Eur Radiol 14:1851-8. 2004
    ..In vitro labeling of human monocytes for MR imaging is most effectively obtained with the approved SPIO Ferucarbotran. Potential subsequent in vivo cell tracking applications comprise, e.g. specific targeting of inflammatory processes...
  26. pmc Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system
    Reinhard Meier
    University of California, San Francisco, USA
    Arthritis Rheum 62:2322-7. 2010
    ..To evaluate a combined indocyanine green-enhanced optical imaging/radiography system for the detection of arthritic joints in a rat model of antigen-induced arthritis...
  27. ncbi request reprint Highly efficient paramagnetic labelling of embryonic and neuronal stem cells
    Martina Rudelius
    Division of Neuropathology, Institute of Pathology, Technical University, Ismaningerstrasse 22, 81675, Munich, Germany
    Eur J Nucl Med Mol Imaging 30:1038-44. 2003
    ....
  28. ncbi request reprint T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning
    Gerhard H Simon
    Department of Radiology, UCSF Medical Center, University of California San Francisco, San Francisco, California 94143, USA
    Eur Radiol 16:738-45. 2006
    ..5T. In conclusion, cellular compartmentalization of ferumoxtran-10 changes proton relaxivity...
  29. doi request reprint Cancer therapy: development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy (small 3/2014)
    Celina Ansari
    Molecular Imaging Program at Stanford and Department of Radiology, Stanford University, 725 Welch Road, Rm 1665, Stanford, CA, 94305 5614, USA
    Small 10:417. 2014
    ..E. Daldrup-Link, and co-workers describe on page 566, this tumor specific drug release reduces the side-effects of cancer therapy. The magnetic core of the nanoparticles allows for MRI monitoring of their distribution in the body. ..
  30. ncbi request reprint Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow
    Heike E Daldrup-Link
    Department of Radiology, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany
    Eur Radiol 12:1557-66. 2002
    ....
  31. pmc Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase
    Sophie E Boddington
    Department of Radiology, University of California, San Francisco, CA 94107 0946, USA
    Cell Transplant 19:55-65. 2010
    ..The technique may be useful for assessing different delivery routes in order to improve the engraftment of transplanted hESC-CMs or other stem cell progenitors...
  32. pmc Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities
    Priyanka Jha
    Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94107, USA
    Cancer Res 70:6109-13. 2010
    ..This review summarizes various new and evolving imaging techniques employed for tracking and monitoring of adoptive natural killer cell immunotherapies...
  33. ncbi request reprint Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas
    Stephan Metz
    Department of Diagnostic Radiology, Technische Universitaet Muenchen, Ismaninger Str 22, 81675, Munich, Germany
    Eur Radiol 16:598-607. 2006
    ..Ferumoxtran-10 improved the detection of focal bone marrow lesions significantly (P<0.05)...
  34. pmc Optical imaging of the peri-tumoral inflammatory response in breast cancer
    Akhilesh K Sista
    Department of Radiology and Biomedical Engineering, University of California, San Francisco, USA
    J Transl Med 7:94. 2009
    ..The purpose of this study was to determine whether injected fluorescently-labeled monocytes accumulate within murine breast tumors and are visible with optical imaging...
  35. ncbi request reprint Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe
    Gerhard H Simon
    The Department of Radiology, S 372, UCSF Medical Center, University of California in San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA
    Eur J Nucl Med Mol Imaging 33:998-1006. 2006
    ..The purpose of this study was to assess the feasibility of inflammation detection in an antigen-induced arthritis model using fluorescent leukocytes and optical imaging...
  36. ncbi request reprint MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent
    Olaf Saborowski
    Department of Radiology, UCSF Medical Center, University of California San Francisco, USA
    Contrast Media Mol Imaging 2:72-81. 2007
    ..05). Histopathology confirmed the presence of folate receptors in the inflamed joints, but not normal joints. Thus, results suggest a specific accumulation of the folate receptor-targeted Gd-chelate P866 in this arthritis model...
  37. ncbi request reprint Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study
    Christopher Klenk
    Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA, USA
    Lancet Oncol 15:275-85. 2014
    ..Our aim was to create a highly effective, clinically feasible, ionising radiation-free staging method based on whole-body diffusion-weighted MRI and the iron supplement ferumoxytol, used off-label as a contrast agent...
  38. doi request reprint Comparison of the diagnostic value of MR imaging and ophthalmoscopy for the staging of retinoblastoma
    Aman Khurana
    Department of Radiology, Stanford University, Stanford, CA, USA
    Eur Radiol 23:1271-80. 2013
    ..To compare the diagnostic value of magnetic resonance (MR) imaging and ophthalmoscopy for staging of retinoblastoma...
  39. doi request reprint Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice
    Tobias Henning
    University of California San Francisco, 185 Berry St, Suite 350, San Francisco, CA 94107, USA
    Acad Radiol 15:342-9. 2008
    ..This study was performed to assess the imaging characteristics and pharmacokinetics of 1,3-Bis-[7-(3-amino-2,4,6-triiodophenyl)-heptanoyl]-2-oleoyl glycerol (DHOG, Fenestra LC), a hepatobiliary contrast agent for microCT...
  40. pmc Iron administration before stem cell harvest enables MR imaging tracking after transplantation
    Aman Khurana
    Department of Radiology and Molecular Imaging Program at Stanford, Stanford University School of Medicine, 725 Welch Rd, Room 1665, Stanford, CA 94305 5654 Department of Communication and Statistics and Department of Materials Science and Engineering, Stanford University, Stanford, Calif Department of Neurology, Comprehensive Cancer Center, Cardiovascular Research Institute and Department of Anatomy, University of California San Francisco, San Francisco, Calif
    Radiology 269:186-97. 2013
    ..To determine whether intravenous ferumoxytol can be used to effectively label mesenchymal stem cells (MSCs) in vivo and can be used for tracking of stem cell transplants...
  41. pmc MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis
    Alexander Nedopil
    Department of Radiology and Biomedical Imaging, UCSF Medical Center, University of California, San Francisco, CA 94143, USA
    Invest Radiol 45:634-40. 2010
    ..To compare magnetic resonance (MR) signal characteristics of contrast agent-labeled apoptotic and viable human mesenchymal stem cells (hMSCs) in matrix-associated stem cell implants...
  42. ncbi request reprint Macromolecular contrast agents for MR mammography: current status
    Heike E Daldrup-Link
    Department of Radiology, Technical University, Ismaninger Strasse 22, 81675 Munich, Germany
    Eur Radiol 13:354-65. 2003
    ..Potential mammographic applications and limitations of various MMCM, defined by either experimental animal testing or clinical testing in patients, are reviewed in this article...
  43. ncbi request reprint Optical imaging of cellular immunotherapy against prostate cancer
    Sidhartha Tavri
    Department of Radiology, University of California San Francisco, San Francisco, CA 941143 0628, USA
    Mol Imaging 8:15-26. 2009
    ..Tumor-targeted NK-92-scFv(MOC31)-zeta cells could be tracked to prostate cancer xenografts with OI...
  44. ncbi request reprint Comparison between gadopentetate and feruglose (Clariscan)-enhanced MR-mammography: preliminary clinical experience
    Heike E Daldrup-Link
    Department of Radiology, Technical University of Munich, Germany
    Acad Radiol 9:S343-7. 2002
  45. pmc MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles
    Heike E Daldrup-Link
    Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, California, USA
    Clin Cancer Res 17:5695-704. 2011
    ....
  46. pmc Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System
    Reinhard Meier
    Department of Radiology, University of California, San Francisco, USA
    J Transl Med 6:73. 2008
    ....
  47. ncbi request reprint Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation
    Heike E Daldrup-Link
    Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California, San Francisco, California 94143 0628, USA
    Microcirculation 11:387-96. 2004
    ....
  48. pmc The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells
    Tobias D Henning
    Department of Radiology, UCSF Medical Center, University of California, San Francisco, CA 94143 0628, USA
    Contrast Media Mol Imaging 4:165-73. 2009
    ..Magnetic labeling of hMSC with ferucarbotran inhibits chondrogenesis in a dose-dependent manner when using simple incubation techniques. When decreasing the incubation time to 4 h, inhibition of chondrogenesis was not significant...
  49. ncbi request reprint Magnetic resonance imaging and tracking of stem cells
    Hossein Nejadnik
    Molecular Imaging Program at Stanford MIPS, Department of Radiology, Stanford School of Medicine, Stanford University, 265 Campus Drive, Room G2045, Lokey Stem Cell Research Building, Stanford, CA 94305, USA
    Methods Mol Biol 1052:167-76. 2013
    ..The following protocol describes stem cell labeling techniques with commercially available gadolinium chelates, which provide positive contrast on T1-weighted MR images, which can be advantageous for specific applications...
  50. pmc Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses
    Qiaoyun Shi
    Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 94305, USA
    Contrast Media Mol Imaging 8:281-8. 2013
    ..i. MR imaging with GEH121333 nanoparticles represents a novel biomarker for TAM assessment. This new USPIO MR contrast agent provides a longer blood half-life and better TAM enhancement compared with the iron supplement ferumoxytol...
  51. pmc Intravenous ferumoxytol allows noninvasive MR imaging monitoring of macrophage migration into stem cell transplants
    Aman Khurana
    Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, 725 Welch Rd, Room 1665, Stanford, CA 94305 5654, USA
    Radiology 264:803-11. 2012
    ..To develop a clinically applicable imaging technique for monitoring differential migration of macrophages into viable and apoptotic matrix-associated stem cell implants (MASIs) in arthritic knee joints...
  52. doi request reprint Cell tracking with optical imaging
    Elizabeth J Sutton
    Department of Radiology, University of California, San Francisco, CA 94143 0628, USA
    Eur Radiol 18:2021-32. 2008
    ..Advantages and limitations of these new OI-based cell-tracking techniques will be discussed. Non-invasive mapping of cells labeled with fluorochromes or OI marker genes has the potential to evolve further within the clinical realm...
  53. pmc Ectopic ureter associated with uterine didelphys and obstructed hemivagina: preoperative diagnosis by MRI
    Zhen J Wang
    Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    Pediatr Radiol 40:358-60. 2010
    ..Accurate preoperative diagnosis of ectopic ureteral insertion associated with this syndrome is important for surgical planning...
  54. pmc MR imaging of ovarian tumors using folate-receptor-targeted contrast agents
    Zhen J Wang
    Department of Radiology, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 0628, USA
    Pediatr Radiol 38:529-37. 2008
    ..Because of its over-expression in many human tumors, the folate receptor (FR) is a promising target for tumor-specific imaging...
  55. doi request reprint Improved fluorescence of indocyanine green in vitro and in vivo after simple cooling procedures
    Sophie Boddington
    Department of Radiology, University of California San Francisco, San Francisco, CA 94107, USA
    Contrast Media Mol Imaging 3:191-7. 2008
    ..This simple cooling method may be immediately helpful to increase the fluorescence signal yield in current ICG-enhanced OI-studies in patients...
  56. pmc Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy
    Celina Ansari
    Molecular Imaging Program at Stanford and Department of Radiology, Stanford University, 725 Welch Road, Rm 1665, Stanford, CA, 94305 5614, USA
    Small 10:566-75, 417. 2014
    ..This novel approach holds the potential to significantly improve targeted cancer therapies, and ultimately enable personalized therapy regimens. ..
  57. doi request reprint Role of diffusion-weighted imaging in differentiating benign and malignant pediatric abdominal tumors
    Rakhee S Gawande
    Department of Radiology, Stanford University, Stanford, CA, USA
    Pediatr Radiol 43:836-45. 2013
    ..Solid malignant tumors are more highly cellular than benign lesions and hence have a restricted diffusion of water molecules...
  58. doi request reprint Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT
    Rakhee S Gawande
    Department of Radiology, Stanford University School of Medicine, and Pediatric Radiology Section, Lucile Packard Children s Hospital, 725 Welch Rd, Stanford, CA 94305 5654, USA
    Radiology 262:613-22. 2012
    ..To evaluate the role of positron emission tomography (PET)/computed tomography (CT) in the differentiation of normal thymus from mediastinal lymphoma and lymphoma recurrence in pediatric patients...
  59. doi request reprint High-resolution MR imaging of the orbit in patients with retinoblastoma
    Andreas M Rauschecker
    Department of Radiology, Lucile Packard Children s Hospital, Stanford University School of Medicine, Palo Alto, CA 94304 1614, USA
    Radiographics 32:1307-26. 2012
    ....
  60. doi request reprint MR imaging of pediatric arthritis
    Heike E Daldrup-Link
    Department of Radiology and Biomedical Imaging, University of California, San Francisco, 512 Parnassus Avenue, San Francisco, CA 94143 0628, USA
    Magn Reson Imaging Clin N Am 17:451-67, vi. 2009
    ....
  61. pmc Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells
    Tobias D Henning
    Department of Radiology, University of California, San Francisco UCSF Medical Center, UCSF, San Francisco, CA 94143 0628, USA
    Magn Reson Med 62:325-32. 2009
    ..These results show that viable cells with compartmentalized iron oxides may-in principle-be distinguished from lysed cells or released iron oxides...
  62. doi request reprint Pediatric liver tumors--a pictorial review
    Priyanka Jha
    Department of Radiology, University of California, San Francisco, CA 94143 0628, USA
    Eur Radiol 19:209-19. 2009
    ..The purpose of this review is to report typical clinical and imaging characteristics of benign and malignant primary liver tumors in children...
  63. ncbi request reprint Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial
    Heike E Daldrup-Link
    Dept of Radiology, Univ Hosp, Technical Univ of Munich, Ismaningerstr 22, 81675 Munich, Germany
    Radiology 229:885-92. 2003
    ..To investigate use of the macromolecular contrast agent feruglose for differentiating and grading of human benign and malignant breast tumors on the basis of their microvascular characteristics...
  64. ncbi request reprint Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability
    Mary E Spilker
    Resource Facility for Population Kinetics, Department of Bioengineering, University of Washington, Seattle, Washington 98195 2255, USA
    J Magn Reson Imaging 22:549-58. 2005
    ..To categorize the disease severity of mammary tumors in an animal model through the application of a novel tumor permeability mixture model within a hierarchical modeling framework...

Research Grants5